Total amount: € 0,00
Indexed/Abstracted in: EMBASE, Scopus
Online ISSN 1827-188X
ADVANCES IN OTOLARYNGOLOGY IN 2011
Kilty S. 1, Desrosiers M. 2
1 Department of Otolaryngology, Head and Neck Surgery, The Ottawa Hospital, University of Ottawa, ON, Canada
2 Division of Otolaryngology, Head and Neck Surgery, Centre Hospitalier de l’Université de Montréal, Université de Montréal Hotel-Dieu de Montreal, QC, Canada
Acute bacterial rhinosinusitis (ABRS) is a common infectious disease that can be challenging to appropriately diagnose. Guidelines for the diagnosis and treatment of ABRS have evolved as our understanding of this disease and its management, as well as the healthcare environment, has changed. Currently, diagnosis remains based upon major signs and symptoms and their duration. Recommendations for treatment, which formerly relied on antibiotics as a first course of action, have relegated the role of antibiotics to severe cases of disease, and now focus on symptom control including the use of intranasal corticosteroids to address the inflammatory component of ABRS.